Natco Pharma Limited — Others, 17-04-2025: Certificate under SEBI (Depositories and Participants) Regulations, 2018

Natco Pharma Limited has announced a board meeting to discuss the financial results for the quarter and half-year ended March 31, 2025. Additionally, the company has received certification confirming that securities submitted for dematerialization have been properly processed. This update reflects the company's commitment to regulatory compliance and efficient management of its shareholder records. Investors may view this as a positive outlook, as timely processing of securities can enhance investor confidence and streamline operations, further supporting the company’s governance and operational integrity.